The Board has granted an effective date prior to August 6, 2014, for the grant of service connection for residuals of papillary thyroid cancer status post thyroidectomy. However, the claim is remanded due to a lack of adequate medical evidence regarding the Veteran's most recent treatment and when he last received radioactive iodine treatment.
The deciding factor: The Board found that an addendum VA opinion was needed to address the Veteran's symptoms and when he last received radioactive iodine treatment or any other therapeutic procedure, prior to August 6, 2014.
- Claimed conditions
- papillary thyroid cancer
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- October 7, 2024
- Citation
- A24063633
Veterans Law Judge
Decisions by this judge: 734 · Granted: 31% (granted or partly granted, in the vetted decisions on this site)
Judge attribution: 2025 complete; earlier years partial.
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation A24063633.
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Remanded (sent back)
The Veteran's papillary thyroid cancer and obstructive sleep apnea claims are being remanded due to the need for additional medical examinations and opinions.
- Denied
The Board denied service connection for papillary thyroid cancer, finding that the evidence does not support a causal relationship between the Veteran's current condition and her military service.
- Denied
The Board denied service connection for papillary thyroid cancer as it is not etiologically related to the Veteran's active military service.
- Granted
The Veteran's papillary thyroid cancer and residuals thereof have been rated as 100 percent disabling since February 1, 2018. Additionally, the Veteran has received a special monthly compensation (SMC) at the housebound rate effective February 1, 2018.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.